Search research articles
Contact Us
Filters
Showing results (221-230 of 288) with videos related to
Page
of 29
Sort By:
International Journal of Radiation Oncology, Biology, Physics
|
November 4, 2019
A Phase 1b Study of Cetuximab and BYL719 (Alpelisib) Concurrent with Intensity Modulated Radiation Therapy in Stage III-IVB Head and Neck Squamous Cell Carcinoma
Lara A Dunn, Nadeem Riaz, Matthew G Fury, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 1, 1996
High-dose edatrexate with oral leucovorin rescue: a phase I and clinical pharmacological study in adults with advanced cancer
K M Pisters, L B Tyson, W Tong, et al.
JAMA Oncology
|
January 20, 2022
Evaluation of Substantial Reduction in Elective Radiotherapy Dose and Field in Patients With Human Papillomavirus-Associated Oropharyngeal Carcinoma Treated With Definitive Chemoradiotherapy
C Jillian Tsai, Sean M McBride, Nadeem Riaz, et al.
The Journal of Pathology
|
May 12, 2017
Frequent IDH2 R172 mutations in undifferentiated and poorly-differentiated sinonasal carcinomas
Snjezana Dogan, Deborah J Chute, Bin Xu, et al.
International Journal of Radiation Oncology, Biology, Physics
|
October 1, 2013
A phase 1 study of everolimus + weekly cisplatin + intensity modulated radiation therapy in head-and-neck cancer
Matthew G Fury, Nancy Y Lee, Eric Sherman, et al.
Cancer Chemotherapy and Pharmacology
|
August 10, 2006
A phase I trial of intermittent high-dose gefitinib and fixed-dose docetaxel in patients with advanced solid tumors
Matthew G Fury, David B Solit, Yungpo Bernard Su, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 28, 2016
A phase II study of axitinib (AG-013736) in patients with incurable adenoid cystic carcinoma
A L Ho, L Dunn, E J Sherman, et al.
Leukemia & Lymphoma
|
December 6, 2024
A Shared Care Model between community and transplant centers facilitates access to allogeneic and autologous transplantation
Joshua A Fein, Agnes McAuliffe, Kimberly Fischer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 24, 1999
Recommendations for the use of antiemetics: evidence-based, clinical practice guidelines. American Society of Clinical Oncology
R J Gralla, D Osoba, M G Kris, et al.
Head & Neck
|
March 19, 2015
Phase II trial of bevacizumab + cetuximab + cisplatin with concurrent intensity-modulated radiation therapy for patients with stage III/IVB head and neck squamous cell carcinoma
Matthew G Fury, Han Xiao, Eric J Sherman, et al.
Page
of 29
Search research articles
Search
Showing results (221-230 of 288) with videos related to
Sort By:
Page
of 29
International Journal of Radiation Oncology, Biology, Physics
|
November 4, 2019
A Phase 1b Study of Cetuximab and BYL719 (Alpelisib) Concurrent with Intensity Modulated Radiation Therapy in Stage III-IVB Head and Neck Squamous Cell Carcinoma
Lara A Dunn, Nadeem Riaz, Matthew G Fury, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 1, 1996
High-dose edatrexate with oral leucovorin rescue: a phase I and clinical pharmacological study in adults with advanced cancer
K M Pisters, L B Tyson, W Tong, et al.
JAMA Oncology
|
January 20, 2022
Evaluation of Substantial Reduction in Elective Radiotherapy Dose and Field in Patients With Human Papillomavirus-Associated Oropharyngeal Carcinoma Treated With Definitive Chemoradiotherapy
C Jillian Tsai, Sean M McBride, Nadeem Riaz, et al.
The Journal of Pathology
|
May 12, 2017
Frequent IDH2 R172 mutations in undifferentiated and poorly-differentiated sinonasal carcinomas
Snjezana Dogan, Deborah J Chute, Bin Xu, et al.
International Journal of Radiation Oncology, Biology, Physics
|
October 1, 2013
A phase 1 study of everolimus + weekly cisplatin + intensity modulated radiation therapy in head-and-neck cancer
Matthew G Fury, Nancy Y Lee, Eric Sherman, et al.
Cancer Chemotherapy and Pharmacology
|
August 10, 2006
A phase I trial of intermittent high-dose gefitinib and fixed-dose docetaxel in patients with advanced solid tumors
Matthew G Fury, David B Solit, Yungpo Bernard Su, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 28, 2016
A phase II study of axitinib (AG-013736) in patients with incurable adenoid cystic carcinoma
A L Ho, L Dunn, E J Sherman, et al.
Leukemia & Lymphoma
|
December 6, 2024
A Shared Care Model between community and transplant centers facilitates access to allogeneic and autologous transplantation
Joshua A Fein, Agnes McAuliffe, Kimberly Fischer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 24, 1999
Recommendations for the use of antiemetics: evidence-based, clinical practice guidelines. American Society of Clinical Oncology
R J Gralla, D Osoba, M G Kris, et al.
Head & Neck
|
March 19, 2015
Phase II trial of bevacizumab + cetuximab + cisplatin with concurrent intensity-modulated radiation therapy for patients with stage III/IVB head and neck squamous cell carcinoma
Matthew G Fury, Han Xiao, Eric J Sherman, et al.
Page
of 29